The results in Fig. 9A show that targeting SIRT3 dramatically reduced ATF4 expression, while no changes were observed in NRF2 and ATF3 expression in U251 cells, suggesting that SIRT3 specifically regulates ATF4 expression in GBM cells. Here, ATF3 is linked to glioblastoma.